1. Home
  2. THH vs CURX Comparison

THH vs CURX Comparison

Compare THH & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TryHard Holdings Limited Ordinary Shares

THH

TryHard Holdings Limited Ordinary Shares

N/A

Current Price

$1.49

Market Cap

11.1M

Sector

N/A

ML Signal

N/A

CURX

Curanex Pharmaceuticals Inc

N/A

Current Price

$4.41

Market Cap

9.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THH
CURX
Founded
2013
2018
Country
Japan
United States
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
9.4M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
THH
CURX
Price
$1.49
$4.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
23.4K
129.4K
Earning Date
05-19-2026
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$305.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.19
$0.18
52 Week High
$56.26
$9.18

Technical Indicators

Market Signals
Indicator
THH
CURX
Relative Strength Index (RSI) 47.03 67.23
Support Level $0.27 $0.32
Resistance Level $4.99 $6.00
Average True Range (ATR) 0.23 0.52
MACD -0.11 -0.13
Stochastic Oscillator 25.72 26.07

Price Performance

Historical Comparison
THH
CURX

About THH TryHard Holdings Limited Ordinary Shares

Tryhard Holdings Ltd is a Japan-based lifestyle entertainment company offering services across the entertainment and hospitality sectors. Its main businesses include event curation, consultancy and management, sub-leasing of venues, and restaurant operations. The company operates through four segments, with the majority of revenue generated from consultancy and management, which provides club planning, operations, event production, entertainer bookings, and sponsorship services. The event curation segment produces both in-house and client events; the sub-leasing segment rents venues and sub-leases them to clubs; and the restaurants segment operates themed dining outlets that complement its entertainment offerings.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Share on Social Networks: